Global Oral Proteins & Peptides Market Forecast to Hit USD 47.2 Billion by 2035, Expanding at 15.3% CAGR - TMR Analysis

Oral Proteins & Peptides Market Outlook 2035

The global oral proteins & peptides industry was valued at US$ 9.8 Billion in 2024 and is projected to reach US$ 47.2 Billion by 2035, expanding at a CAGR of 15.3% from 2025 to 2035. The market is witnessing rapid growth driven by increasing demand for protein- and peptide-based therapeutics, rising prevalence of chronic diseases, and advancements in oral delivery technologies. Innovations in peptide stabilization, formulation, and bioavailability enhancement are accelerating adoption in pharmaceuticals, nutraceuticals, and functional food applications.

Do not miss the latest market intelligence. Get your sample report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1962

Market Overview

Oral proteins & peptides are biologically active molecules delivered through oral formulations to treat or manage various medical conditions. These molecules offer therapeutic benefits similar to injectable biologics but with improved patient compliance, ease of administration, and better market accessibility.

The industry is benefiting from growing research in peptide therapeutics, enhanced drug delivery systems such as enteric coatings, nano- and micro-encapsulation, and enzyme inhibitors that improve stability and absorption. Rising interest in peptide-based nutraceuticals, weight management, and metabolic health supplements further supports market expansion.

Analyst Viewpoint

The Oral Proteins & Peptides Market is transitioning from traditional injectable biologics to oral delivery platforms that enhance patient adherence and expand therapeutic reach.

Analysts emphasize three key trends shaping the market landscape:
1. Enhanced Oral Bioavailability: Innovative formulations and carriers improve absorption and stability of oral peptides.
2. Therapeutic Diversification: Applications across diabetes, oncology, gastrointestinal disorders, and metabolic diseases are broadening market potential.
3. Patient-Centric Solutions: Oral formulations are preferred for chronic therapies due to convenience and reduced injection-related complications.

Companies focusing on scalable, safe, and cost-effective oral protein and peptide delivery solutions are poised for significant growth.

Analysis of Key Players in the Oral Proteins & Peptides Market

Leading companies in the oral proteins and peptides market focus on product innovation, strategic collaborations, and clinical validation to strengthen their market positions. These firms invest heavily in R&D, particularly in advanced microfluidic and non-invasive delivery technologies, expand distribution networks, and offer integrated service solutions to enhance customer loyalty and market reach.

Prominent players in the global market include:
• Novo Nordisk A/S
• AbbVie Inc.
• Pfizer Inc.
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Sanofi S.A.
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Novartis AG
• Eli Lilly and Company
• Biocon Limited
• Oramed Pharmaceuticals Inc.
• Proxima Limited
• Chiesi Farmaceutici S.p.A.
• Tarsa Therapeutics Inc.
• Other Prominent Players.
These players are focusing on product pipeline expansion, collaborations, and geographic expansion to strengthen market presence and enhance therapeutic coverage.

Key Developments in the Oral Proteins & Peptides Market

• January 2025: AbbVie acquired Nimble Therapeutics for USD 4.6 billion, gaining access to Nimble's oral peptide IL23R inhibitor, currently in preclinical development for psoriasis, thereby expanding its immunology pipeline.

• December 2024: Merck entered a global licensing agreement with Hansoh Pharma for HS-10535, an investigational oral GLP-1 receptor agonist. Under this USD 1.9 billion deal, Merck secured exclusive rights to develop, manufacture, and commercialize the compound.

Discuss Implications for Your Industry Request Sample Research PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1962

Key Growth Drivers

1. Rising Prevalence of Chronic Diseases
Diabetes, cardiovascular disorders, and obesity drive demand for oral peptide therapeutics.
2. Advances in Oral Delivery Technologies
Microencapsulation, nanocarriers, and enzyme inhibitors enhance drug stability and absorption.
3. Patient Convenience & Compliance
Oral formulations reduce injection-related barriers, improving adherence and outcomes.
4. R&D Investment & Innovation
Increased clinical trials and research in novel peptides fuel market expansion.
5. Growth in Nutraceutical Applications
Functional foods and dietary supplements incorporating bioactive peptides are gaining popularity.

Opportunities

• Next-Generation Oral Peptides
Development of GLP-1 analogs, insulin mimetics, and peptide-based vaccines.
• Integration with Digital Health
Smart pill technologies and adherence monitoring systems.
• Emerging Markets
Expansion in Asia-Pacific and Latin America with rising healthcare infrastructure and affordability.
• Combination Therapies
Oral peptide formulations combined with conventional drugs for enhanced efficacy.
• Functional Foods & Nutraceuticals
Inclusion of bioactive peptides in wellness products to capitalize on preventive healthcare trends.

Challenges

• Low Bioavailability & Stability Issues
Oral peptides are susceptible to enzymatic degradation and low absorption.
• High R&D Costs
Developing safe and effective oral peptide therapies requires substantial investment.
• Regulatory Hurdles
Strict clinical trials and approval processes delay market entry.
• Patient Awareness & Acceptance
Limited understanding of oral peptide therapies may slow adoption in certain regions.
• Manufacturing Complexities
Scaling up peptide synthesis and oral formulation production is technically challenging.

Market Segmentation

By Product Type:
Therapeutic Peptides • Nutraceutical Peptides • Functional Proteins

By Application:
Diabetes & Metabolic Disorders • Cardiovascular Disorders • Gastrointestinal Disorders • Oncology • Anti-inflammatory & Immunomodulatory • Others

By Route of Administration:
Oral Tablets • Capsules • Liquid Formulations • Nutraceutical Integration

By End-Use Industry:
Pharmaceuticals • Biotechnology • Nutraceuticals • Research & Clinical Labs

By Region:
North America • Europe • Asia-Pacific • Middle East & Africa • Latin America

Future Prospectus

By 2035, the oral proteins & peptides market will be defined by enhanced oral bioavailability, diversified therapeutic applications, and patient-centric innovations. Advanced delivery systems, AI-assisted formulation design, and combination therapies will drive adoption and improve patient outcomes. North America and Europe will continue leading in innovation and approvals, while Asia-Pacific is expected to witness strong growth due to increasing healthcare investments, rising chronic disease burden, and expanding consumer awareness.

To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=1962<ype=S

What Is in This Report?

• Global and regional market forecasts (2024-2035)
• Analysis of growth drivers, restraints, and opportunities
• Detailed segmentation by product type, application, and region
• Technology and delivery innovations for oral peptides
• Competitive landscape with key company profiles
• Regulatory, safety, and reimbursement considerations
• SWOT and Porter's Five Forces analysis
• Strategic roadmap for market entry and expansion

Why Buy This Report?

1. Data-Driven Insights - Make informed strategic decisions based on reliable forecasts.
2. Innovation Radar - Track emerging oral peptide technologies and delivery solutions.
3. Competitive Benchmarking - Evaluate key players' pipelines, partnerships, and product launches.
4. Market Entry & Expansion Strategy - Identify high-growth regions and applications.
5. Regulatory & Reimbursement Guidance - Navigate complex clinical and approval pathways.
6. Future-Proof Planning - Align R&D and business strategies with patient-centric trends.

Conclusion

The Oral Proteins & Peptides Market is evolving rapidly, offering convenient, patient-friendly, and therapeutically effective solutions for chronic diseases, metabolic disorders, and functional health applications. Companies that invest in innovative oral delivery systems, ensure regulatory compliance, and expand into emerging markets will capture significant growth opportunities through 2035.

More Trending Research Reports-

• Topical Pharmaceuticals Market - https://www.transparencymarketresearch.com/topical-pharmaceuticals-market.html
• Peptide Therapeutics Market - https://www.transparencymarketresearch.com/peptide-therapeutics-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.